Home > Insider Trading > Filing (0001209191-15-035342)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1037760	Cepheid	CPHD	Laboratory Analytical Instruments (3826)	770441625

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1240656	H Joseph Smith	C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089	Evp, Bus Dev And Gc	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-04-20	34,352	$9.08	48,837	No	4	M	Direct
Common Stock	Disposition	2015-04-20	34,352	$55.18	14,485	No	4	S	Direct
Common Stock	Acquisiton	2015-04-21	57,514	$19.85	71,999	No	4	M	Direct
Common Stock	Disposition	2015-04-21	51,308	$54.02	20,691	No	4	S	Direct
Common Stock	Disposition	2015-04-21	6,206	$54.98	14,485	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2015-04-20	34,352	$0.00	34,352	$9.08
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2015-04-21	57,514	$0.00	57,514	$19.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2006-01-01	2015-04-27	No	4	M	Direct
0	2009-04-24	2015-04-24	No	4	M	Direct

Footnotes

The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
The sales price reported is the weighted average sale price for the number of shares sold. Full information regarding the number of shares sold at each separate price will be supplied upon request by the Securities & Exchange Commission staff, the Issuer or a security holder of the Issuer.
1/48th of the shares subject to the grant vest and become exercisable monthly from the grant date, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.